13D·WATCH Activist + Insider Intelligence Live feed Blog About Pilot
SCHEDULE Filed 2025-11-12 Event 2025-08-22 SEC 0001193125-25-277894 →

MITHRIL II LP Invivyd, Inc. IVVD

Stake: 4.80% Shares: 11,241,580 CUSIP: 00534A102 Class: Common Stock, $0.0001 par value per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)
0 transactions
0 buys · 0 sales · 0 awards/exercises
Issuer Cluster
7 13D/G filings on this issuer
6 other filings besides this one
Filer Track Record
3 filings by this filer
2 other filings in the data moat
Short Interest · settle 2026-03-31
DTC 8.44
26,469,699 shares short · +7.9% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers
1 holder · $41.13M
Point72 Asset Mgmt

Other 13D/G Filings on Invivyd, Inc.

FiledFormFilerStakeShares
2025-12-29 SCHEDULE Adimab, LLC 7.30% 20,262,170 view →
2025-11-07 SCHEDULE Polaris Venture Partners V, L.P. 3.00% 7,008,590 view →
2024-01-22 SC Adimab, LLC view →
2022-07-05 SC MITHRIL II LP view →
2022-03-30 SC Polaris Venture Partners V, L.P. view →
2022-03-30 SC MITHRIL II LP view →

Other Filings by MITHRIL II LP

FiledFormIssuerStakeShares
2022-07-05 SC Adagio Therapeutics, Inc. IVVD view →
2022-03-30 SC Adagio Therapeutics, Inc. IVVD view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →